STRO - Sutro Biopharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

STRO is currently covered by 6 analysts with an average price target of $6.65. This is a potential upside of $5.64 (558.42%) from yesterday's end of day stock price of $1.01.

Sutro Biopharma's activity chart (see below) currently has 77 price targets and 64 ratings on display. The stock rating distribution of STRO is 33.33% BUY, 44.44% HOLD and 22.22% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.16% with an average time for these price targets to be met of 170.9 days.

Highest price target for STRO is $3, Lowest price target is $0.8, average price target is $1.96.

Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 11-Aug-2025. First documented stock forecast 21-Oct-2018.

Currently out of the existing stock ratings of STRO, 3 are a BUY (33.33%), 4 are a HOLD (44.44%), 2 are a SELL (22.22%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$3

$1.99 (197.03%)

$5

2 months 7 days ago
(11-Aug-2025)

1/2 (50%)

$2.22 (284.62%)

99

Buy

$2

$0.99 (98.02%)

$11

4 months 3 days ago
(15-Jun-2025)

4/11 (36.36%)

$1.12 (127.27%)

402

Sell

$0.8

$-0.21 (-20.79%)

$1

5 months ago
(18-May-2025)

2/3 (66.67%)

$-0.08 (-9.09%)

33

Hold

$2

$0.99 (98.02%)

$12

7 months 2 days ago
(16-Mar-2025)

0/12 (0%)

$1.07 (115.05%)

Hold

$2

$0.99 (98.02%)

$8

7 months 5 days ago
(13-Mar-2025)

2/10 (20%)

$1.19 (146.91%)

708

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is STRO (Sutro Biopharma) average time for price targets to be met?

On average it took 170.9 days on average for the stock forecasts to be realized with a an average price target met ratio 26.16

Which analyst has the current highest performing score on STRO (Sutro Biopharma) with a proven track record?

KONSTANTINOS APRILAKIS

Which analyst has the most public recommendations on STRO (Sutro Biopharma)?

Konstantinos Aprilakis has 5 price targets and 3 ratings on STRO

Which analyst is the currently most bullish on STRO (Sutro Biopharma)?

Konstantinos Aprilakis with highest potential upside - $33.99

Which analyst is the currently most reserved on STRO (Sutro Biopharma)?

Tazeen Ahmad with lowest potential downside - -$0.21

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?